Orion Biotechnology
Unlocking the Therapeutic Potential of Metabolic GPCRs
18 employees · est. 2017 · Ottawa, Canada
Silence Therapeutics plc
Precision Engineered Medicines to Silence Diseases
109 employees · est. 1999 · London, United Kingdom
Silence Therapeutics plc is the older company (2017 vs 1999); Silence Therapeutics plc is the larger of the two.
Side-by-Side Comparison
| Metric | Orion Biotechnology | Silence Therapeutics plc |
|---|---|---|
| Founded | ||
| Founded | 2017 | 1999 older |
| Headquarters | ||
| Headquarters | Ottawa, Canada | London, United Kingdom |
| Employees | ||
| Employees | 18 | 109 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $14.24M | $248.70M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | GPCR-targeted drug discovery, Development of next-gen therapeutics for obesity and metabolic disorders, PROcisionX discovery platform services, Structure-activity matrix optimization | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers specializing in metabolic disorders | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Engineering, GPCR-targeted Therapeutics, Proprietary Technology Platform, Next Generation Therapeutics, G Protein-Coupled Receptors, Undruggable Complex GPCRs, Cancer Immunotherapy, Biologic Therapeutics, Chemokine Analogue Inhibitors, Serious Unmet Medical Needs, Cell Receptor Pharmacology, Technology Commercialization, Clinical Operations, Immunology, Translational Medicine | Not tracked yet |
| Website | ||
| Website | orionbiotechnology.com | silence-therapeutics.com |
About Orion Biotechnology
Orion Biotechnology, founded in 2017, is at the forefront of innovation in the Biotechnology and Health Care sectors. Based in Canada, the company specializes in precision engineering therapeutics that target G Protein-Coupled Receptors (GPCRs), a challenging area in drug development. Utilizing its...
About Silence Therapeutics plc
Silence Therapeutics is a biotechnology company founded in 1999 in the United Kingdom, specializing in RNA interference (RNAi) technology. The company's validated mRNAi GOLD™ platform has positioned it as a sought-after partner for pharmaceutical companies seeking to harness the benefits of siRNA in...
We will tell you when either one moves
BounceWatch watches Orion Biotechnology and Silence Therapeutics plc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Orion Biotechnology and Silence Therapeutics p... — by email.
Frequently Asked Questions
Compare Orion Biotechnology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Orion Biotechnology on 11 Sep 2024, and Silence Therapeutics plc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
